Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report
L Thorlacius, P Theut Riis… - British Journal of …, 2018 - academic.oup.com
An inappropriate immunological response to an unknown antigen has been suggested to
play a role in the pathogenesis of hidradenitis suppurativa (HS). Studies have identified …
play a role in the pathogenesis of hidradenitis suppurativa (HS). Studies have identified …
Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality
JR Ingram, PN Woo, SL Chua… - British Journal of …, 2016 - academic.oup.com
More than 50 interventions have been used to treat hidradenitis suppurativa (HS), and so
therapy decisions can be challenging. Our objective was to summarize and appraise …
therapy decisions can be challenging. Our objective was to summarize and appraise …
Insulin resistance in hidradenitis suppurativa: a case–control study
I Vilanova, JL Hernández, C Mata… - Journal of the …, 2018 - Wiley Online Library
Background The association between chronic inflammatory diseases, such as rheumatoid
arthritis and psoriasis, and insulin resistance (IR) has been well established. Hidradenitis …
arthritis and psoriasis, and insulin resistance (IR) has been well established. Hidradenitis …
Interventions for hidradenitis suppurativa
JR Ingram, PN Woo, SL Chua… - Cochrane Database …, 2015 - cochranelibrary.com
Interventions for hidradenitis suppurativa - Ingram, JR - 2015 | Cochrane Library Skip to
Content Cookies Our site uses cookies to improve your experience. You can find out more …
Content Cookies Our site uses cookies to improve your experience. You can find out more …
High-dose, high-frequency infliximab: a novel treatment paradigm for hidradenitis suppurativa
MH Ghias, AD Johnston, AJ Kutner… - Journal of the American …, 2020 - Elsevier
Background The permanent disfigurement associated with hidradenitis suppurativa (HS)
necessitates early aggressive disease intervention. Although limited data support the use of …
necessitates early aggressive disease intervention. Although limited data support the use of …
Biologics and small molecule inhibitors for treating hidradenitis suppurativa: a systematic review and meta-analysis
Background: The treatment guidelines for hidradenitis suppurativa (HS) vary among different
countries, and several biologics and small molecule inhibitors have been tested for treating …
countries, and several biologics and small molecule inhibitors have been tested for treating …
Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne
C Vinkel, SF Thomsen - International Journal of Dermatology, 2017 - Wiley Online Library
Autoinflammatory syndromes associated with hidradenitis suppurativa (HS) and/or acne are
rare but potentially debilitating disorders if not diagnosed and treated correctly. They share a …
rare but potentially debilitating disorders if not diagnosed and treated correctly. They share a …
The ABC of hidradenitis suppurativa: a validated glossary on how to name lesions
D Lipsker, F Severac, M Freysz, E Sauleau, J Boer… - Dermatology, 2016 - karger.com
Background: The precise clinical description of skin lesions observed in some patients with
hidradenitis suppurativa (HS) can be extremely difficult. Objective: Establishing a validated …
hidradenitis suppurativa (HS) can be extremely difficult. Objective: Establishing a validated …
Defining fistular patterns in hidradenitis suppurativa: impact on the management
A Martorell, G Giovanardi, P Gomez-Palencia… - Dermatologic …, 2019 - journals.lww.com
BACKGROUND Recent studies suggest that there are different fistular subtypes in
hidradenitis suppurativa (HS) patients who are associated with variable therapeutic …
hidradenitis suppurativa (HS) patients who are associated with variable therapeutic …
Swiss practice recommendations for the management of hidradenitis suppurativa/acne inversa
RE Hunger, E Laffitte, S Läuchli, C Mainetti… - Dermatology, 2017 - karger.com
Hidradenitis suppurativa (HS) is a painful, inflammatory, debilitating skin disease with a
chronic intermittent course. The central pathogenetic event seems to be the occlusion of the …
chronic intermittent course. The central pathogenetic event seems to be the occlusion of the …